10x Genomics Inc - Class A Shares Close the Day 16.4% Higher - Daily Wrap
The company saw its shares close the day 16.4% higher than yesterday, with trading volume higher than its 30 day average.
May 13, 2022 by Kwhen Finance Editors
10x Genomics Inc - Class A (TXG) shares closed today 16.4% higher than it did at the end of yesterday. The stock is currently down 68.0% year-to-date, down 66.9% over the past 12 months, and down 9.7% over the past five years. Today, the Dow Jones Industrial Average rose 1.4%, and the S&P 500 rose 2.4%.
Trading Activity
- Shares traded as high as $51.33 and as low as $36.76 this week.
- Shares closed 77.2% below its 52-week high and 29.6% above its 52-week low.
- Trading volume this week was 0.6% lower than the 10-day average and 47.0% higher than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.9.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| 10x Genomics Inc - Class A | 16.4 | -68.0 | -66.9 | -79.5 | 16.7 |
| Dow Jones Industrial Average | 1.4 | -10.9 | -3.7 | -12.9 | 2.5 |
| S&P 500 Index | 2.4 | -15.2 | -0.8 | -17.1 | 3.0 |
| Health Care | 1.3 | -10.5 | 2.3 | -11.7 | 3.6 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 222.0%
- The company's stock price performance over the past 12 months lags the peer average by 380.7%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| 10x Genomics Inc - Class A | TXG | -50.2 | -68.0 | -66.9 | -79.5 | 16.7 |
| Peer Avg | N/A | 33.0 | -21.1 | -13.9 | -33.5 | 16.4 |
| Neurocrine Biosciences, Inc. | NBIX | 112.6 | -1.2 | -11.1 | -22.5 | 16.5 |
| Maravai LifeSciences Holdings Inc - Class A | MRVI | 19.6 | -20.0 | -11.6 | -48.0 | 42.7 |
| MeiraGTx Holdings plc | MGTX | 0 | -63.3 | -33.0 | -63.6 | 6.5 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: